Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $87,152 - $105,872
-10,400 Reduced 10.36%
90,000 $877,000
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $165,330 - $193,052
16,700 Added 19.95%
100,400 $994,000
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $865,458 - $1.07 Million
83,700 New
83,700 $966,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $423,612 - $543,168
-49,200 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $112,267 - $166,239
-13,100 Reduced 21.03%
49,200 $443,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $1.01 Million - $1.63 Million
-124,400 Reduced 66.63%
62,300 $768,000
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $2.04 Million - $4.1 Million
-304,900 Reduced 62.02%
186,700 $1.68 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $2.91 Million - $4.77 Million
445,000 Added 954.94%
491,600 $4.82 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $534,072 - $832,320
-86,700 Reduced 65.04%
46,600 $321,000
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $912,687 - $1.77 Million
112,400 Added 537.8%
133,300 $1.23 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $325,622 - $418,209
20,900 New
20,900 $328,000
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $749,926 - $1.23 Million
-51,400 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $71,604 - $87,210
-3,400 Reduced 6.2%
51,400 $1.11 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $2.62 Million - $3.86 Million
-156,300 Reduced 74.04%
54,800 $1.33 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $3.35 Million - $4.43 Million
200,700 Added 1929.81%
211,100 $3.61 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $116,792 - $198,640
10,400
10,400 $197,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.